nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.12.2023 | editorial

ASCO 2023—partnering with patients: the cornerstone of cancer care and research

verfasst von: Assoc. Prof. PD Dr. Gabriel Rinnerthaler

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Excerpt

For the 2023 annual meeting of the American Society of Clinical Oncology (ASCO), over 250 abstracts were finally selected for oral presentations, and over 2000 abstracts for poster presentation. To spread this enormous gain of knowledge, new ways of information exchange have become increasingly important. With webcasts and news tickers, presentations at international congresses can be followed in realtime from at home. Furthermore, continuing medical education events and published reviews illuminate the presented data from different perspectives. In this special edition, Austrian experts summarize the important and most clinically relevant data from this year’s ASCO. …

Vorheriger Artikel Editorial

Nächster Artikel HER2 in focus—gastric cancer

Spiegelberg JA. Renal cell carcinoma—ASCO update 2023. memo. 2023; https://doi.org/10.1007/s12254-023-00918-w.CrossRef

Winder T, Reimann P. Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer. 2023in;16(3). DOI.

Djanani A. ASCO update—HCC (hepatocellular carcinoma) and CC (cholangiocellular carcinoma). memo. 2023; https://doi.org/10.1007/s12254-022-00845-2.CrossRef

Pichler J. ASCO 2023: new treatment options in CNS tumors. memo.16(4):2023. https://doi.org/10.1007/s12254-023-00915-z.

Titel: ASCO 2023—partnering with patients: the cornerstone of cancer care and research
verfasst von: Assoc. Prof. PD Dr. Gabriel Rinnerthaler
Publikationsdatum: 01.12.2023
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 4/2023
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-023-00930-0

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2023

HER2 in focus—gastric cancer

Prostate cancer special—part 1

Renal cell carcinoma

Focal therapy in intermediate- and high-risk prostate cancer

Challenges in prevention, early detection, and management of febrile neutropenia in adult patients with solid tumors

Fifth-line HER2-directed therapy for metastatic adenocarcinoma of the gastroesophageal junction